2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, hydrochloride (1:1), 5mg

2,4,5-Trifluorophenylboronic acid, 97.0%, 5g

3-Formylphenoxyacetic acid, 97%, 1g

(dimethylamino)(4-fluorophenyl)acetic acid hydrochloride, 95.0%, 10g

4-Biphenylglyoxal hydrate, 95.0%, 1g

Methyl Indazole-6-carboxylate>97.0%(GC)1g

N,N'-Diphenylformamidine>98.0%(GC)(T)25g

Ethyl 4-(4-bromophenyl)-4-oxobutyrate, 95.0%, 5g

(3-(o-Tolyl)isoxazol-5-yl)methanol, 95.0%, 250mg

butyl[(2,4-dimethoxyphenyl)methyl]amine, 95.0%, 10g

2-Benzyl-4,5-dihydro-1H-imidazole, 95.0%, 5g

N,N-Bis(1H-1,2,3-benzotriazol-1-ylmethyl)hydroxylamine, 1g

(S)-(+)-DBD-APy [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg